(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

QUANTIFY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

QUANTIFY

ST13

US500000074689726

Class

5

Filing

74689726

Registration

1979628

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

08/11/2026

Trademark type

Combined

Nice classes

5

Filing date

06/19/1995

Registration date

06/11/1996

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/22/2026

Last transaction

08/11/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

03/15/1995

First use in commerce

03/15/1995

Drawing code

5

Owner type

03

Owner location

HERCULES, CA, US

Examiner

SARAI, BALDEV

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

BIO-RAD LABORATORIES, INC.
Hematronix, Inc.

Representatives

Lamara Parnell Procopio, Cory, Hargreaves & Savitch LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

medical diagnostic quality control reagents for use in urine analysis

Publications

History of USPTO decisions and trademark events.

28 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

07/22/2026

RNL3

REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)

07/22/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

07/22/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/22/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

05/21/2026

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

06/11/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/02/2016

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

06/23/2016

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

06/23/2016

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/23/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/23/2016

E89R

TEAS SECTION 8 & 9 RECEIVED

04/04/2016

CFIT

CASE FILE IN TICRS

06/13/2007

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

07/22/2006

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

07/22/2006

PLGL

ASSIGNED TO PARALEGAL

07/19/2006

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

04/20/2006

E89R

TEAS SECTION 8 & 9 RECEIVED

04/20/2006

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/17/2002

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

07/23/2002

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

06/10/2002

MAIL

PAPER RECEIVED

06/10/2002

R.PR

REGISTERED-PRINCIPAL REGISTER

06/11/1996

PUBO

PUBLISHED FOR OPPOSITION

03/19/1996

NPUB

NOTICE OF PUBLICATION

02/16/1996

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/01/1995

CNEA

EXAMINER'S AMENDMENT MAILED

11/27/1995

DOCK

ASSIGNED TO EXAMINER

11/21/1995

Continuous trademark protection

Get notified about every new filing that threatens QUANTIFY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.